Scientific Publications by FDA Staff

Ir J Med Sci 2008 Mar;177(1):11-7

Critically ill newborns with multiple organ dysfunction: assessment by NEOMOD score in a tertiary NICU.

Janota J, Simak J, Stranak Z, Matthews T, Clarke T, Corcoran D

Janota, J (reprint author), Rotunda Hosp, Dept Paediat, Parnell Sq, Dublin 1, Ireland Rotunda Hosp, Dept Paediat, Dublin 1, Ireland US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA Inst Care Mother & Child, Prague, Czech Republic Childrens Hosp, Dublin, Ireland

BACKGROUND: The neonatal multiple organ dysfunction score (NEOMOD) predicts mortality during the first 28 days of life, and provides information on organ functions influencing mortality. AIM: To test the predictive and descriptive accuracy of NEOMOD in very low birth weight (VLBW) infants. METHODS: The system was used in 112 infants. It evaluates the central nervous system (CNS), coagulation, respiratory, gastrointestinal (GIT), cardiovascular (CVS), renal system, and acid-base balance in 24-h intervals during the first 28 days of life. RESULTS: A NEOMOD of >/=9 was associated with 100% mortality. A receiver operating characteristic (ROC) curve was used for assessing the accuracy of NEOMOD score in prediction of mortality. The area under curve (AUC) attained by NEOMOD was 0.93 for mortality. CONCLUSIONS: The NEOMOD evaluates daily the severity of the multiple organ dysfunction syndrome (MODS) and is an accurate predictor of mortality.